Current Recommendations for Secondary Stroke Prevention
Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial | The BMJ
Blogging Stroke – Role of Combined Clopidogrel and Aspirin in High-Risk TIA and Stroke: Discussing the POINT Trial
THALES Secondary Efficacy | BRILINTA® (ticagrelor) tablets | For HCPs
Safety of Low-Dose Aspirin in Endovascular Treatment for Intracranial Atherosclerotic Stenosis | PLOS ONE
Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines | Stroke and Vascular Neurology
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA | NEJM
EMNote.org - DAPT for non-AFib TIA #Stroke #TIA #FOAMED https://www.emnote.org/emnotes/transient-ischemic-attack-tia | Facebook
Stroke Guidelines | The International Aspirin Foundation
Clopidogrel and Aspirin in Acute Ischemic Stroke and High‐Risk TIA | Semantic Scholar
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke
The THALES Trial: Ticagrelor and Aspirin vs Aspirin Alone in Acute Ischemic Stroke or TIA - REBEL EM - Emergency Medicine Blog
Stroke - clinical overview Stroke - clinical overview
ED TIA Patient Case Presentation Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral. - ppt download
What is TIA or Ministroke: Preventing TIA | Bayer® Aspirin
Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic Cerebrovascular Disease: JACC Scientific Expert Panel - ScienceDirect
Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomize
Stroke Guidelines | The International Aspirin Foundation
Immediate aspirin after mini-stroke substantially reduces risk of major stroke | University of Oxford
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial - The Lancet
Dual Antiplatelet Therapy Lowers Stroke, Death Rates in Ischemic Stroke/TIA Patients Better than Aspirin Alone - Physician's Weekly
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA | NEJM
Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack | Neurology
George Hanbury Csalódottság kalapács tia aspirin dose Incidens, esemény prototípus sitcom
![PDF] The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cfc35389ebc64406fddbc60b7c6a2d907ce71de1/3-Table1-1.png "PDF] The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design | Semantic Scholar")
PDF] The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design | Semantic Scholar
